Unión Europea - español - EMA (European Medicines Agency)

vertex pharmaceuticals (ireland) limited - ivacaftor - fibrosis quística - otros productos del sistema respiratorio - kalydeco tablets are indicated:as monotherapy for the treatment of adults, adolescents, and children aged 6 years and older and weighing 25 kg or more with cystic fibrosis (cf) who have an r117h cftr mutation or one of the following gating (class iii) mutations in the cystic fibrosis transmembrane conductance regulator (cftr) gene: g551d, g1244e, g1349d, g178r, g551s, s1251n, s1255p, s549n or s549r (see sections 4. 4 y 5. in a combination regimen with tezacaftor/ivacaftor tablets for the treatment of adults, adolescents, and children aged 6 years and older with cystic fibrosis (cf) who are homozygous for the f508del mutation or who are heterozygous for the f508del mutation and have one of the following mutations in the cftr gene: p67l, r117c, l206w, r352q, a455e, d579g, 711+3a→g, s945l, s977f, r1070w, d1152h, 2789+5g→a, 3272 26a→g, and 3849+10kbc→t. in a combination regimen with ivacaftor/tezacaftor/elexacaftor tablets for the treatment of adults, adolescents, and children aged 6 years and older with cystic fibrosis (cf) who have at least one f508del mutation in the cftr gene (see section 5. kalydeco granules are indicated for the treatment of infants aged at least 4 months, toddlers and children weighing 5 kg to less than 25 kg with cystic fibrosis (cf) who have an r117h cftr mutation or one of the following gating (class iii) mutations in the cftr gene: g551d, g1244e, g1349d, g178r, g551s, s1251n, s1255p, s549n or s549r (see sections 4. 4 y 5. in a combination regimen with ivacaftor/tezacaftor/elexacaftor for the treatment of cystic fibrosis (cf) in paediatric patients aged 2 to less than 6 years who have at least one f508del mutation in the cftr gene.

Unión Europea - español - EMA (European Medicines Agency)

vertex pharmaceuticals (ireland) limited - lumacaftor, ivacaftor - fibrosis quística - otros productos del sistema respiratorio - orkambi comprimidos está indicado para el tratamiento de la fibrosis quística (fq) en pacientes mayores de 6 años y más que son homocigotos para la mutación f508del en el gen cftr. orkambi granules are indicated for the treatment of cystic fibrosis (cf) in children aged 1 year and older who are homozygous for the f508del mutation in the cftr gene.

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

bgp products operations, s.l. - ibuprofeno - excipientes: sacarina sodica,sacarosa,laurilsulfato de sodio,hidrogenocarbonato de sodio,carbonato sodico,croscarmelosa sodica - productos antiinflamatorios y antirreumÁticos no esteroideos - derivados del ácido propiónico - ibuprofeno

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

labiana pharmaceuticals, s.l.u - fosfomicina trometamol - granulado para soluciÓn oral - 3 g - fosfomicina trometamol 3 g - fosfomicina

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

inretail pharma s.a. - colina; lecitina de soja; - granulos para solucion oral - por parche; colina 250.000000 mg; lecitina de soja 1725.000000 mg; - vitaminas con minerales

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

natural center company s.a.c. - granulos

Guatemala - español - Gobierno de Guatemala, Ministerio de Salud Pública y Asistencia Social (Departamento de Regulación y Control de Productos Farmacéuticos y Afines)

vitamin shoppe global, llc. - granulado para solución oral

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

support and representation pharma s.a.c. -

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

avalon pharmaceutical peru s.a.c. -

Ecuador - español - Agencia Nacional de Regulación, Control y Vigilancia Sanitaria

e-z-em inc. [us] united states - bicarbonato de sodio, usp - 55,14 g acido cÍtrico anhidro, usp - 38,21 g - grÁnulos efervescentes - cada 100 g contiene: bicarbonato de sodio, usp - 55,14 g Ácido cÍtrico anhidro, usp - 38,21 g